Headache Impact Test (HIT-6)
Posted on July 31 2023,
HIT-6 is a reliable and valid tool for discriminating headache impact across episodic and chronic migraine. It was designed to provide a global measure of adverse headache impact and was developed to use in screening and monitoring patients with headaches in both clinical practice and clinical research.
The four headache impact severity categories are little or no impact (49 or less), some impact (50–55), substantial impact (56–59), and severe impact (60–78).
Reference: Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6TM) across episodic and chronic migraine. Cephalalgia. 2011;31(3):357-367. doi:10.1177/0333102410379890.
Sun, Jan 04, 26
Long-Term Safety of Anti-CGRP Monoclonal Antibodies
A comprehensive meta-analysis of over 4,300 patients reveals that erenumab, galcanezumab, fremanezumab, and eptinezumab maintain good tolerability beyond 12 months. Only 3% of patients stopped treatment due to adverse events,...
Read MoreThu, Jan 01, 26
Alternate Nostril Breathing Protocol for Migraine
Alternate nostril breathing is a simple yogic technique that's showing real promise for migraine prevention. Unlike acute treatments, this practice builds nervous system resilience over time - making attacks less...
Read MoreFri, Dec 26, 25
Why Migraine and Jaw Pain Go Together: New Research (2025) Explains the Link
A 2025 systematic review of over 10,000 patients confirms a strong bidirectional link between migraine and temporomandibular disorders. People with migraine are 6 times more likely to develop TMD, while...
Read More
